Kura Oncology, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: La Jolla CA United States (2014)

Organization Overview

First Clinical Trial
2015
NCT02383927
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Kura Oncology, Inc.